ArticleJGH open : an open access journal of gastroenterology and hepatology2025

Higher Absolute Lymphocyte Counts and Lower Des-γ-Carboxyprothrombin Levels After Treatment Initiation Are Associated With the Clinical Efficacy of Tremelimumab Plus Durvalumab Combination Therapy for Hepatocellular Carcinoma.

Yuta Inoue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.